Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Eighth International Congress on the Future of Breast Cancer
Grand Wailea
Wailea, HI
July 22-25, 2009
Wednesday, Jul 22, 2009
| 6:30 am | Registration |
| 7:00 am | Breakfast Sunrise Session: Interactive Case Discussion with the Experts |
| 8:00 am | Welcome and Introductions Joyce O’Shaughnessy |
| 8:05 am | Best of Breast Cancer Science: Metastasis and Breast Cancer Self Seeding Larry Norton |
| Targeting Metastases Moderator: Joyce O’Shaughnessy |
|
| 8:35 am | Presession Survey |
| 8:45 am | Characterization of Circulating Tumor Cells Using a Microfluidic Device Shyamala Maheswaran |
| 9:05 am | Unraveling the Mystery of Metastases Andrea Richardson |
| 9:25 am | Host Factors Influencing Breast Cancer Outcomes Rowan Chlebowski |
| 9:45 am | Advances in Cytotoxic Agents for Metastatic Breast Cancer Jo Anne Zujewski |
| 10:00 am | Panel Discussion |
| 10:20 am | Break |
| Optimizing Breast Cancer Local Control Moderator: Lori J. Pierce |
|
| 10:40 am | Intensity-Modulated Radiation Therapy: Is It the Standard of Care? Lori J. Pierce |
| 11:00 am | SLN Update: Can We Omit Axillary Surgery and Radiation in SLN-Positive Disease? Eleftherios Mamounas |
| 11:20 am | Sequencing of Systemic Therapy and Radiation: Where Are We Now? Jennifer Bellon |
| 11:40 am | Gene Profiling and Molecular Markers for Locoregional Recurrence Bruce G. Haffty |
| 12:00 pm | Panel Discussion |
| 12:20 pm | Clinical Dilemma: Is Postmastectomy Radiation the Standard of Care for Patients With 1-3 Positive Nodes? Bruce G. Haffty |
| 12:50 pm | Postsession Survey |
| 1:00 pm | Adjourn |
| Workshop: Novel Molecular Diagnostics with Evolving Clinical Utility (Non-CME Activity) | |
| 4:00 pm | Multiple Sub-types of HER2-positive Breast Cancer Michael P. Bates |
| 4:20 pm | Predicting Chemotherapy Sensitivity Holly Gallion |
| 4:40 pm | Microarray-based Diagnostic Assays for Breast Cancer Shelly Gunn |
| 5:00 pm | Single Cell Pathways Analysis Alessandra Cesano |
| 5:20 pm | Novel Molecular Assays for Triple-Negative Breast Cancer Joseph A. Sparano |
| 5:40 pm | Adjourn |
| 7:00 pm-9:00 pm | Welcome Reception |
Educational Grants
An educational grant for this activity was provided by:
- Genentech BioOncology
- Bristol-Myers Squibb
- Eli Lilly and Company
- Merck Oncology
- AstraZeneca
- Genomic Health
- ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
- Roche Laboratories, Inc.
- sanofi-aventis U.S.